Abstract
Evidence reveals that patients at highest risk for poor outcomes are less likely than those at low risk to receive appropriate therapy, a phenomenon termed the “treatment-risk paradox.” In a prospective cohort study, researchers looked at use of guideline-recommended medications in patients with angiographically proven coronary heart disease, with a focus on functional capacity and depressive symptoms (factors likely to “fly under the radar” because they are not coded). One month after catheterization, nearly 4000 patients reported on …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
